Deletion of ENO1 sensitizes pancreatic cancer cells to gemcitabine via MYC/RRM1-mediated glycolysis. - Lu, Yingpeng; Ma, Hongqin; Xiong, Xiaoxiao; Du, Yusheng; Liu, Li; Wang, Ji; Zhao, Wenxing (Scientific Reports, 2025)